- Stage 2 Multiple Myeloma
Overview
Stage 2 Multiple Myeloma is considered an intermediate stage of the disease, positioned between Stage 1 (the earliest stage) and Stage 3 (the most advanced stage). In this phase, the disease is more aggressive than Stage 1 but not as severe as Stage 3.
Stage 2 does not meet the criteria for either Stage 1 or Stage 3, making it a distinct category in the staging system.
What tests will I need and Why?
Blood and Imaging tests are done to understand your general health, confirm your diagnosis and determine your cancer stage.
A bone marrow biopsy is a procedure where a small sample of bone marrow is taken, usually from your hip bone, using a thin needle. This helps doctors examine your cells and identify the type of myeloma cells present. This information is important for finding the best treatment option for you.
If your treatment team has not already performed tests to determine your cancer’s features and stage, please ask your doctor when these tests will be performed.
Re-read this summary as needed and then tap, “Compare My Treatment Options Now“. Our unique Comparison Page will help you understand your FDA-approved treatment options including, who can help you pay for your treatment, where and how each is given and what side-effects you may experience.
Replay this Audio as often as needed and then take a look at our Commonly Searched Questions below.
Cancerresearchuk.org